No Data
CSI Commodity Equity Index overview: oil prices rise, geopolitical tensions escalate, gold prices increase, copper prices continue to fall for eight consecutive weeks.
Crude oil prices are rising due to heightened geopolitical tensions from Russia to Iran, while the strengthening stock market increases the attractiveness of risk assets. Gold prices also received a boost from safe-haven demand and are expected to record the largest weekly gain since March of last year. London copper is facing an eight-week decline, likely setting the longest weekly losing streak since 2019, as the rising dollar puts pressure on csi commodity equity index priced in dollars. Crude oil: WTI has risen over 6% this week due to the intensified geopolitical tensions between Iran and Russia.
xiong'an new power technology (300152.SZ): The related technology has not yet been applied in the low-altitude economy and commercial aerospace fields.
Gelonghui, November 21 - xiong'an new power technology (300152.SZ) stated on the investor interaction platform that as of now, the company's related technology has not yet been applied in the low-altitude economy and commercial aerospace fields.
xiong'an new power technology (300152.SZ): Not producing fuel cell energy.
According to Gelonghui on November 14, xiong'an new power technology (300152.SZ) stated on the investor interaction platform that as of now, the company's main business is energy-saving combustion, with the main products being energy-saving combustion ignition equipment and the utilization of combustion control systems, and it has not produced fuel cell energy.
Zhao Yin International: maintains a "buy" rating for Giant Biologics with a target price of 66.15 Hong Kong dollars.
CMB International released a research report maintaining a "buy" rating for Giant Bio (02367), remaining bullish on the rapid growth of the company's skincare products, and expects injectable collagen products to be approved in Q1 2025. The earnings forecast for FY24-26 has been slightly adjusted upward, and based on the DCF model, the target price has been raised to 66.15 HKD (WACC: 10.9%, perpetual growth rate: 3.0%). The main points from CMB International are as follows: the singles' day sales in 2024 concluded with impressive online growth for the company's two core brands, Kefu Mei and Keli Jin. During the singles' day sales period (October 8 to November 11), Kefu Mei
Express News | Ishijian China: Anesthesiology and other fields will become key business directions for the company.
Express News | Industry professionals are hotly discussing the new wave of mergers and acquisitions.
No Data
No Data